Nucleic acids and corresponding proteins entitled 202P5A5...

Details Nucleic acids and corresponding proteins entitled 202P5A5... Nucleic acids and corresponding proteins entitled 202P5A5...

2006-10-11

2011-11-15

Yu, Misook (Department: 1643)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

Reexamination Certificate

active

08057996

ABSTRACT:
A novel gene 202P5A5 and its encoded protein, and variants thereof, are described wherein 202P5A5 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 202P5A5 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 202P5A5 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 can be used in active or passive immunization.

REFERENCES:
patent: 5460951 (1995-10-01), Kawai et al.
patent: 5539084 (1996-07-01), Geysen
patent: 5785973 (1998-07-01), Bixler et al.
patent: 5840839 (1998-11-01), Wang et al.
patent: 6893818 (2005-05-01), Afar et al.
patent: 2001/0051344 (2001-12-01), Shalon et al.
patent: 2003/0054375 (2003-03-01), Rosen et al.
patent: 2003/0087250 (2003-05-01), Monahan et al.
patent: 2004/0053250 (2004-03-01), Tang et al.
patent: 2007/0014801 (2007-01-01), Gish et al.
patent: 1412309 (2003-04-01), None
patent: 1477123 (2004-02-01), None
patent: 1 074 617 (2001-02-01), None
patent: WO9952942 (1999-10-01), None
patent: WO-00/18916 (2000-04-01), None
patent: WO-00/58473 (2000-10-01), None
patent: WO-01/55343 (2001-08-01), None
patent: WO-01/57271 (2001-08-01), None
patent: WO-01/57272 (2001-08-01), None
patent: WO-01/60860 (2001-08-01), None
patent: WO-01/70979 (2001-09-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/92581 (2001-12-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/29086 (2002-04-01), None
patent: WO-02/30268 (2002-04-01), None
patent: WO-02/59271 (2002-08-01), None
patent: WO-02/60317 (2002-08-01), None
patent: WO-02/70539 (2002-09-01), None
patent: WO-02/71928 (2002-09-01), None
patent: WO-03/006618 (2003-01-01), None
patent: WO-03/083047 (2003-10-01), None
patent: WO-03/083074 (2003-10-01), None
patent: WO-03/087768 (2003-10-01), None
patent: WO-2004/015108 (2004-02-01), None
patent: WO-2004/016736 (2004-02-01), None
patent: WO-2004/046342 (2004-06-01), None
patent: WO-2004/065545 (2004-08-01), None
Kroese et al., Genetics in Medicine, 2004, 6: 475-480.
Lucentini, The Scientist, 2004, vol. 18, p. 20.
Hacker, Gut, 1997, 40: 623-627.
Pennisi, Science, 1998, 281(5384): 1787-1789.
Yerushalmi et al., Gene, 2001, vol. 265, pp. 55-60.
Caillou et al., Journal of Clinical Endocrinology and Metabolism, 2001, vol. 86, pp. 3351-3358.
Conklin et al., Briefings in Bioinformatics, 2000, vol. 1, pp. 93-99.
Drivas et al., (Identification of Novel ras family genes in a human teratocarcinoma cell line by oligonucleotide screening In: The ras-Superfamily of GTPases, Lacal and McCormick, Eds., 1993, pp. 329-347).
Database Geneseq, accession No. ABZ11512 (2003).
Database Geneseq, accession No. ADJ70535 (2004).
Database Geneseq, accession No. BD160241 (2003).
Database Geneseq, accession No. BD570305 (2003).
Supplementary European Search Report for EP 03737110.1, mailed Sep. 7, 2007, 5 pages.
Wilanowski et al., Mechanisms of Development (2002) 114(1-2):37-50.
Riott et al., Immunology, Fourth Edition (1996) Mosby, p. 7.9-7.11.
Jain, Sci. Am. (1994) 171:58-65.
Gura, Science (1997) 278(5340):1041-1042.
MSNBC News Services, “Mixed results on new cancer drug” Nov. 2000.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Alberts et al., Molecular Biology of the Cell, 3rdEdition (1994) p. 465.
Mallampalli et al., Biochem. J. (1996) 38:333-341.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Database Genbank, Accession No. ABP69295, Sep. 12, 2002.
Database Genbank, Accession No. Q9H8B8, Ota et al., 2005.
International Search Report for PCT/US03/18906, mailed on Aug. 4, 2006, 5 pages.

Affiliated with

Also associated with

Rating

Nucleic acids and corresponding proteins entitled 202P5A5... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids and corresponding proteins entitled 202P5A5..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids and corresponding proteins entitled 202P5A5... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4278730